## UBS Stock Pitch Competition: UnitedHealth Group (UNH)
This project contains the full valuation analysis and investment thesis for UNH, 
combining a DCF and comparable company analysis. 

**Key Highlights:**
- WACC: 7.45%, Terminal Growth: 2%
- Target Price: $525.82 (â‰ˆ50% upside)
- Valuation Methods: DCF + Peer Comps (Cigna, Elevance, Humana)
- Tools: Excel, Data analysis, financial modeling, scenario sensitivity
